ORIC Pharmaceuticals Inc.
ORIC | NASDAQ
$13.33
+$0.66 (+5.21%)
Sep 22, 2026, 2:32 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -41.49M | -35.77M | -30.51M | -32.59M | -36.36M | -30.02M | -36.31M | -34.57M | -31.96M | -25.01M | -28.33M | -25.48M | -22.94M | -23.95M | -20.85M | -24.83M | -20.29M | -23.16M | -22.77M | -18.43M | -21.01M | -16.51M |
Depreciation & Amortization | 264K | 270K | 320K | 288K | 310K | 302K | 304K | 270K | 272K | 261K | 263K | 257K | 259K | 253K | 247K | 221K | 247K | 251K | 229K | 217K | 222K | 229K |
Stock-Based Compensation | 7.09M | 6.9M | 6.28M | 5.63M | 6.57M | n/a | 5.2M | 5.06M | 5M | 4.96M | 3.92M | 3.86M | 3.83M | 3.61M | 3.13M | 3.29M | 4.09M | 3.95M | 3.5M | 3.4M | n/a | 2.74M |
Other Working Capital | 21K | -4M | 2.11M | 2.14M | -780K | -575K | 1.35M | 1.63M | -434K | -2.41M | 1.98M | -277K | -1.03M | 1.1M | 2.72M | 1.87M | -1.58M | -536K | 132K | 703K | -1.13M | 1.43M |
Other Non-Cash Items | 291K | 162K | -240K | -587K | -591K | 5.43M | -1.63M | -1.95M | -2.3M | -2.4M | -2.11M | -1.92M | -1.25M | -861K | -580K | -370K | -94K | 42K | 148K | 330K | 3.31M | 441K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.24M | -4M | 1.66M | 2.14M | -780K | -8.49M | 4.38M | 2.39M | 3.37M | -8.17M | 1.98M | 3.63M | -1.03M | 311K | 2.72M | 2.37M | -1.73M | -3.8M | 2.61M | 2.34M | 928K | -1.81M |
Operating Cash Flow | -31.61M | -32.44M | -22.48M | -25.11M | -30.84M | -32.78M | -28.05M | -28.8M | -25.63M | -30.35M | -24.27M | -19.65M | -21.15M | -20.63M | -15.33M | -19.32M | -17.78M | -22.72M | -16.28M | -12.14M | -16.55M | -14.9M |
Capital Expenditures | -356K | -2K | -387K | -35K | -63K | -387K | -219K | -418K | -333K | -218K | -57K | -77K | -405K | -310K | -287K | -401K | -667K | -723K | -389K | -233K | -135K | -182K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 310K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -47.78M | -77.97M | -45.29M | -165.5M | -124.37M | -64.66M | -34.63M | -54.01M | -48.89M | -114.4M | -28.97M | -110.99M | -55.9M | -43.39M | -31.63M | -61.02M | -45.54M | -99.94M | -36.76M | -7.7M | n/a | -25.17M |
Sales Maturities Of Investments | 60M | 60M | 62.5M | 55M | 47.5M | 87.5M | 77.5M | 77.5M | 67.5M | 52.75M | 49.99M | 53.24M | 36.99M | 56.48M | 60.22M | 60.74M | n/a | 10M | 37.5M | 43M | 82.5M | 66M |
Other Investing Acitivies | n/a | n/a | 223K | n/a | n/a | n/a | n/a | -969K | n/a | n/a | n/a | n/a | n/a | -310K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 11.86M | -17.98M | 16.98M | -110.54M | -76.93M | 22.45M | 42.66M | 23.07M | 18.28M | -61.87M | 20.96M | -57.83M | -19.31M | 12.78M | 28.3M | -685K | -46.2M | -90.66M | 351K | 35.07M | 82.37M | 40.65M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -993K | n/a | -993K | 377K | n/a | n/a | n/a | n/a | 198K | 227K | n/a | 174K | n/a | -207K | n/a | n/a | n/a | n/a | -1.41M | n/a | n/a |
Financial Cash Flow | 828K | 61.14M | 1.5M | 109.45M | 134.3M | 253K | 575K | 126K | 816K | 125.2M | 453K | 31K | 85.17M | n/a | 24.79M | 1K | 415K | 16K | 813K | 48.59M | 58K | 16K |
Net Cash Flow | -18.91M | 10.73M | -4M | -26.2M | 26.53M | -10.07M | 15.18M | -5.6M | -6.53M | 32.98M | -2.85M | -77.45M | 44.72M | -7.85M | 37.76M | -20M | -63.56M | -113.36M | -15.12M | 71.52M | 65.87M | 25.76M |
Free Cash Flow | -31.96M | -32.44M | -22.87M | -25.15M | -30.91M | -33.16M | -28.27M | -29.22M | -25.96M | -30.57M | -24.33M | -19.72M | -21.55M | -20.94M | -15.62M | -19.72M | -18.44M | -23.44M | -16.67M | -12.38M | -16.69M | -15.08M |
Adj. Free Cash Flow | -39.05M | -39.34M | -29.15M | -30.78M | -37.48M | -33.16M | -33.48M | -34.27M | -30.95M | -35.53M | -28.25M | -23.59M | -25.38M | -24.55M | -18.75M | -23.01M | -22.54M | -27.39M | -20.17M | -15.77M | -16.69M | -17.83M |
Maintenance CapEx | -264K | -2K | -320K | -35K | -63K | -302K | -219K | -270K | -272K | -218K | -57K | -77K | -259K | -253K | -247K | -221K | -247K | -251K | -229K | -217K | -135K | -182K |
Growth CapEx | -92K | n/a | -67K | n/a | n/a | -85K | n/a | -148K | -61K | n/a | n/a | n/a | -146K | -57K | -40K | -180K | -420K | -472K | -160K | -16K | n/a | n/a |
Owner Earnings | -31.87M | -32.44M | -22.8M | -25.15M | -30.91M | -33.08M | -28.27M | -29.07M | -25.9M | -30.57M | -24.33M | -19.72M | -21.4M | -20.88M | -15.58M | -19.54M | -18.02M | -22.97M | -16.51M | -12.36M | -16.69M | -15.08M |
Add to Watchlist
Select watchlists to add or remove ORIC